Publicaties | RIVM

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? Experience from the Netherlands

Construction of opa-positive and opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine

Prevalence and clinical course in invasive infections with meningococcal endotoxin variants

Meningococcal C specific immune responses

Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients

Meningococcal disease serogroup B. Updated information for the Dutch Health Council